Chem. J. Chinese Universities ›› 2019, Vol. 40 ›› Issue (12): 2494.doi: 10.7503/cjcu20190206

• Analytical Chemistry • Previous Articles     Next Articles

Multiple Analyses of Tumor Invasion Based on an Integrated Microfluidic System with Bi-directional Solute Concentration Gradient

Jie WANG,Yu ZHANG,Min YU,Jin FANG()   

  1. Key Laboratory of Cell Biology, Ministry of Public Health, Key Laboratory of Medical Cell Biology, Ministry of Education, Department of Cell Biology, School of Life Sciences, China Medical University, Shenyang 110122, China
  • Received:2019-04-08 Online:2019-12-04 Published:2019-12-04
  • Contact: Jin FANG E-mail:jfang@cmu.edu.cn
  • Supported by:
    ? Supported by the National Natural Science Foundation of China(81672920);the National Natural Science Foundation of China(20875103)

Abstract:

A simple integrated microfluidic system with continuous 2D concentration gradient for multiple evaluation of tumor invasion was developed. The continuous bi-directional gradient was established vertically by solute diffusion and horizontally by Christmas tree-shaped network. The microfluidic system managed to quantitatively evaluate different invasive potentials of different cell lines(HEK-293, MCF-7, SGC-7901) and effects on tumor invasion by multiple factors. Human gastric cancer SGC-7901 cells were driven to invade into matrix under vertical FBS(Fetal bovine serum) gradient and revealed an increased invasion distance with the obvious concentration gradient. Given the continuous bi-directional gradient of FBS and Staurosporine, the invasion distance and increased number of human gastric cancer SGC-7901 cells were gradually inhibited along with the increase of drug concentration. In conclusion, the established bi-directional gradient microfluidic system provides multifunctional application in investigation of tumor invasion, cell interaction under complex environmental factors or combined chemotherapy.

Key words: Microfluidic, Concentration gradient, Tumor, Invasion, Drug screening

CLC Number: 

TrendMD: